Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Establishment of a new cell line (TAYA) of clear cell adenocarcinoma of the ovary and its radiosensitivity.

Oncology - 1 Jan 2002

Saga Yasushi, Suzuki Mitsuaki, Machida Shizuo, Ohwada Michitaka, Sato Ikuo

Abstract excerpt

A new cell line (TAYA) was established from ascites of a patient with clear cell adenocarcinoma of the ovary, and the sensitivity of the cell line to various anticancer drugs and radiation was investigated. The 50% growth inhibitory concentrations (IC50) (nM) of various anticancer drugs were: cisplatin >10,000, paclitaxel 80, SN-38 (irinotecan metabolite) 460, and gemcitabine >10,000, showing that the cells had a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Clear Cell
Share to Chromosomes
Share to Colorimetry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dose-Response Relationship, Radiation

Share to Genes, Tumor Suppressor

Share to Phosphoric Monoester Hydrolases

Share to PTEN Phosphohydrolase

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 11914605
DOI: 10.1159/000048265

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Establishment of a new cell line (TAYA) of clear cell adenocarcinoma of the ovary and its radiosensitivity.PMID 11914605Read ↗

Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.Semantic proximity Read ↗

A clear cancer cell line (150057) derived from human endometrial carcinoma harbors two novel mutations.Semantic proximity Read ↗

Establishment and characterization of a cell line (HCH-1) originating from a human clear cell carcinoma of the ovary.Semantic proximity Read ↗

Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the OvarySemantic proximity Read ↗

New therapies for clear cell ovarian carcinoma.Semantic proximity Read ↗

Antitumor Activity and Induction of TP53-Dependent Apoptosis toward Ovarian Clear Cell Adenocarcinoma by the Dual PI3K/mTOR Inhibitor DS-7423Semantic proximity Read ↗

The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinomaSemantic proximity Read ↗

Establishment and characterization of a new cell line (SKS) from neuroendocrine small cell carcinoma of the uterine cervix and its chemosensitivity.Semantic proximity Read ↗

Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomasSemantic proximity Read ↗

Identification of Overexpression and Amplification of ABCF2 in Clear Cell Ovarian Adenocarcinomas by cDNA Microarray AnalysesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.